
CalciMedica fell 92.4% from $16.15 to $1.22, behind the S&P 500's +12.7%. Its worst day was Jan 28 (−75.3%), and its low came Oct 19 at $1.02.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
CalciMedica shares rose 27.7%, while the S&P 500 rose 1.5%.
+27.7% · S&P 500 +1.5%
CalciMedica shares rose 29.6%, while the S&P 500 rose 0.9%.
+29.6% · S&P 500 +0.9%
Story events cover the past 12 months · Times ET
CalciMedica closed at its highest level of the year, 108.7% above where the year started.
+2.3% · S&P 500 +0.2%
CalciMedica shares fell 75.3%, while the S&P 500 fell 0.0%.
−75.3%, the year's worst day · S&P 500 0.0%
EPS of $-9.85 missed the $-8.80 estimate on $0.00 revenue.
+14.4% · S&P 500 −0.9%
EPS of $1.50 beat the $-1.40 estimate on $0.00 revenue.
+6.6% · S&P 500 −0.2%
CalciMedica shares rose 30.3%, while the S&P 500 fell 0.7%.
+30.3%, the year's best day · S&P 500 −0.7%
EPS of $-2.25 missed the $-1.50 estimate on $0.00 revenue.
−0.2% · S&P 500 −0.3%
CalciMedica closed at its lowest level of the year, 93.7% below where the year started.
−1.9% · S&P 500 +0.4%
EPS of $-0.24 beat the $-1.17 estimate on $0.00 revenue.
−9.6% · S&P 500 −0.4%
Where it ended: a close of $1.22 on Nov 12, 2026. Up next: FY 2026 earnings on Mar 2, 2027 (EPS est. $-2.80, revenue est. $20.0M).
Nothing in the past 12 months.
All CALC dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CALC and SPY from Benzinga historical bars. Not investment advice.